L R Prosnitz1, J J Wu, J Yahalom. Show Affiliations » 1. Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, USA.
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Combined Chemotherapy Protocols/therapeutic useBleomycin/administration & dosageClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicCombined Modality TherapyDacarbazine/administration & dosageDoxorubicin/administration & dosageHodgkin Disease/pathologyHodgkin Disease/radiotherapyHumansNeoplasms, Radiation-Induced/etiologyNeoplasms, Second Primary/etiologyRadiotherapy/adverse effectsRadiotherapy/methodsRadiotherapy DosageRadiotherapy, Adjuvant/adverse effectsVinblastine/administration & dosage
Substances： See more » BleomycinVinblastineDacarbazineDoxorubicin
Year: 1996 PMID： 8689432 DOI： 10.3109/07357909609012164
Source DB: PubMed Journal: Cancer Invest ISSN： 0735-7907 Impact factor: 2.176